Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00079482
Status:
COMPLETED
Last Update Posted:
2016-07-21
First Post:
2004-03-08
Brief Title:
Study of CEP-701 Lestaurtinib in Patients With Acute Myeloid Leukemia AML
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-10
Start Date Type:
None
Primary Completion Date:
2009-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-01
Completion Date Type:
ACTUAL
First Submit Date:
2004-03-08
First Submit QC Date:
March 9 2004
Study First Post Date:
2004-03-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2013-08-27
Disp First Submit QC Date:
August 27 2013
Disp First Post Date:
2013-09-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-07-19
Last Update Post Date:
2016-07-21
Last Update Post Date Type:
ESTIMATED